Cancer
HER-2/neu 369-377 (HLA-A*02:01) KIFGSLAFL
Product number: EP07858_5
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
KIFGSLAFL is a linear peptidic epitope studied as part of Receptor tyrosine-protein kinase erbB-2 from Rattus norvegicus (brown rat) and Receptor tyrosine-protein kinase erbB-2 from Homo sapiens (human).ï¾ This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays HER-2/neu 369-377 peptide KIFGSLAFL (HLA-A*02:01) for stimulation of T-cells. Single peptide (KIFGSLAFL) for stimulation of human Her-2/neu-specific CD8+ T-cells.
TechData
| Sequence: | KIFGSLAFL |
| Gene: | ERBB2 |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Receptor tyrosine-protein kinase erbB-2 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |